Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Sulfonylurea that boosts insulin release. | Once-daily sulfonylurea. |
| Body system | Diabetes & Weight | Diabetes & Weight |
| Drug class | Sulfonylureas | Sulfonylureas |
| Supply | Prescription onlyWHO essential medicine | Prescription only |
| Main uses | Type 2 diabetes | Type 2 diabetes |
| How it works | Tells your pancreas to release more insulin. | Releases more insulin from the pancreas. |
| Starts working | — | — |
| Half-life | 10–12 hours | 5–8 hours |
| Typical adult dose | 40–320 mg a day (split if over 160 mg); modified-release 30–120 mg once a day with breakfast. | 1–4 mg once a day with breakfast (maximum 6–8 mg). |
| Forms | Tablet, Modified-release tablet | Tablet, Combination tablets with metformin |
| Common side effects | Low blood sugar, Weight gain, Stomach upset | Low blood sugar, Weight gain, Dizziness |
| Serious side effects | Severe hypoglycaemia, Liver or blood problems (rare) | Severe hypoglycaemia |
| Don't take if | Type 1 diabetes or ketoacidosis; Severe kidney or liver impairment; Allergy to sulfonylureas; Taking miconazole | Type 1 diabetes or ketoacidosis; Severe kidney or liver impairment; Allergy to sulfonylureas |
| Alcohol | Best to limit. Alcohol raises the risk of severe low blood sugar. | Best to limit. Alcohol raises the risk of severe low blood sugar. |
| Pregnancy | Usually avoidedUsually switched to insulin or metformin. | Usually avoidedSwitch to insulin. |
| Breastfeeding | Usually avoidedAvoid; insulin preferred. | Usually avoidedAvoid; insulin preferred. |
| In use since | 1972 | 1995 |
| Brand names | United Kingdom: Diamicron, ZicronIndia: Glizid, Reclide, DiamicronAustralia: Diamicron MR | United States: AmarylUnited Kingdom: AmarylIndia: Amaryl, Glimy, Glimestar, Gemer (with metformin) |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | A10BB09 | A10BB12 |
Taken together
- MinorGliclazide + Glimepiride: More risk of low blood sugar
Both medicines lower blood sugar; combinations are common but hypos become more likely.